Investment
Features
FeesSafety
Academy
More
Pluang+

Textron set to beat Q1 earnings with strong aviation and helicopter growth, shares could rise 34%.

Company Fundamentals
28 Apr 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Textron (TXT) is expected to report better-than-expected Q1 earnings, driven by strong growth in its Textron Aviation segment and the ramp-up of its Bell helicopter division, including the MV-75 program. Despite trading at a discount to similar aerospace and defense companies, Textron maintains a clean balance sheet with low leverage. The analyst models Q1 EPS at $1.42, above the street estimate of $1.30, and projects a 34% upside to $118 per share based on a 17.5x earnings multiple and $6.75 EPS for the year. Key risks include reliance on US government revenue (27%), cyclicality in business jets, and sensitivity to macroeconomic conditions, especially in aviation.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Global clinical trials market to reach $176.32B by 2030, driven by AI and decentralized research advances

Global clinical trials market to reach $176.32B by 2030, driven by AI and decentralized research advances

The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...

Market News
Bullish
4 hours ago
Projects near Sonoma water facilities cut wildfire risk, protecting key infrastructure.

Projects near Sonoma water facilities cut wildfire risk, protecting key infrastructure.

California American Water and Sonoma County Fire District completed projects reducing wildfire risk around water facilities in Sonoma County. The efforts included clearing flammable vegetation near critical infrastructure like water storage tanks and...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App